What is Zelnorm?
Zelnorm manufactured by (Novartis Pharmaceuticals Corporation) is a selective serotonin receptor agonist. It works by stimulating the release of certain chemicals in the intestines that increase the movement of stools (bowel movement) through the bowel. Zelnorm was approved by the FDA on July 24, 2002.
What is Zelnorm prescribed for?
Zelnorm is a prescription drug approved for short term treatment of women with irritable bowel syndrome (IBS).
August 20, 2004 – Zelnorm received FDA approval for the treatment of men and women less than 65 years of age with chronic idiopathic constipation.
What are the dangers associated with Zelnorm?
March 30, 2007 – the Food and Drug Administration (FDA) recalled Zelnorm, after 29 different clinical trials involving over 18,000 patients demonstrated that users of Zelnorm are at a rate of 700-800 percent greater risk of experiencing heart attacks, strokes and angina. The FDA determined that the risk of heart attack, stroke, serious injury or death far outweighs the benefits of treating a non-life threatening irritable bowel syndrome. Click here to see the FDA Public Health Advisory for Zelnorm.
What can I do if I have been injured by Zelnorm?
Beasley Allen is currently investigating potential Zelnorm lawsuits for people that suffered death or catastrophic injury from a cardiac event after ingesting Zelnorm for at least 12 weeks, you may be entitled to compensation. For a free legal consultation, contact us today!